Tolvaptan, a vasopressin receptor antagonist, results in the excretion of electrolyte free water and is effective in raising the serum sodium in patients with SIADH. It should be used with caution in the treatment of severe, symptomatic hyponatremia,
If you want to change selection, open document below and click on "Move attachment"
- (no access) - MKSAP_17.pdf, p3514
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|